Global Lugol's Iodine Market Strategic Research Report

Scope of the Report

Lugol"s iodine, also known as Lugol"s solution, first made in 1829, is a solution of iodine named after the French physician J.G.A. Lugol. Lugol"s iodine solution is often used as an antiseptic and disinfectant, a starch indicator, to replenish iodine deficiency, to protect the thyroid gland from radioactive materials (e.g. "fallout"), and for emergency disinfection of drinking water.Lugol"s was often used in the treatment of gout and was used as a first line treatment for hypothyroidism in adults.It consists of 5% iodine (I2) and 10% potassium iodide (KI) in 85% distilled water with a total iodine content of 130 mg/mL. Potassium iodide makes the iodine water soluble through the formation of the I3- ion. It is obtained from chemists and pharmacists who are licensed to prepare and dispense the solution.It can be used as a cell stain, making the cell nuclei more visible and for preserving phytoplankton samples.During colposcopy, Lugol"s iodine is applied to the vagina and cervix. Normal tissue stains brown, while tissue suspicious for cancer does not stain, and appears pale compared to the surrounding tissue. Biopsy of suspicious tissue can then be performed. This is called Schiller"s test.

This report presents a comprehensive overview of the global Lugol's Iodine market, covering market size and forecast, segmentation by product type and application, competitive landscape, leading players and regional and country-level outlook.

Segment by Type

• Lugol's Iodine for Microscopy
• Lugol's Iodine for the Gram Staining Method
• Others

Segment by Application

• Laboratory
• Hospital
• Clinic
• Others

Who Can Use This Report?

This report is written for decision-makers who need a clear, data-backed view of the global Lugol's Iodine market:

• Manufacturers, suppliers and solution providers benchmarking their position and planning product, capacity and go-to-market strategy
• Distributors, channel partners and end users in Laboratory, Hospital, Clinic evaluating demand and sourcing options
• Investors, financial analysts and consultants assessing growth opportunities, competitive dynamics and M&A potential
• Government agencies, industry associations and research institutions tracking industry developments and policy impact